Influenza News and Research RSS Feed - Influenza News and Research

Influenza (the flu) is a contagious respiratory illness caused by influenza viruses. It can cause mild to severe illness, and at times can lead to death. The best way to prevent the flu is by getting a flu vaccination each year. Every year in the United States, on average 5% to 20% of the population gets the flu; more than 200,000 people are hospitalized from flu complications, and; about 36,000 people die from flu-related causes. Some people, such as older people, young children, and people with certain health conditions, are at high risk for serious flu complications.
Study points respiratory viruses as the most common cause of childhood pneumonia

Study points respiratory viruses as the most common cause of childhood pneumonia

Respiratory viruses, not bacterial infections, are the most commonly detected causes of community-acquired pneumonia in children, according to new research released Feb. 26 in the New England Journal of Medicine. [More]
Researchers examine individuals' confidence or reluctance in vaccination decision-making

Researchers examine individuals' confidence or reluctance in vaccination decision-making

Researchers explore individuals' confidence or reluctance to vaccinate their families and the associated effects on global health, in a collection published on February 25, 2015 by the open-access journal, PLOS Currents: Outbreaks. The collection is accompanied by the editorial "Hesitancy, trust and individualism in vaccination decision-making" by Jonathan E. Suk et al. from the European Centre for Disease Prevention and Control. [More]
Gates Foundation awards $2.5 million to support development of vaccine-filled microneedles

Gates Foundation awards $2.5 million to support development of vaccine-filled microneedles

The Georgia Institute of Technology and Micron Biomedical have been awarded $2.5 million in grants from the Bill & Melinda Gates Foundation to advance the development of dissolvable microneedle patches for polio immunization. The patches will be studied to evaluate their potential role as part of the worldwide efforts to eradicate polio. [More]
Medicago receives task order from HHS BARDA to manufacture anti-Ebola virus monoclonal antibodies

Medicago receives task order from HHS BARDA to manufacture anti-Ebola virus monoclonal antibodies

Medicago, a leading company in the development and production of plant-based vaccines and therapeutics, announced today that it has received a task order from the Biomedical Advanced Research and Development Authority at the U.S. Department of Health and Human Services for three anti-Ebola virus monoclonal antibodies (mAbs) with expected performance comparable to that of ZMapp, from Mapp Biopharmaceutical. [More]
Study: Airport screening for disease often misses infected travellers, but can be improved

Study: Airport screening for disease often misses infected travellers, but can be improved

Scientists have shown that airport screening for disease will often miss half or more of infected travellers, but can be improved by customizing to pathogens. [More]
IDRI Announces $4M BARDA Cooperative Agreement To Establish Adjuvant Hub

IDRI Announces $4M BARDA Cooperative Agreement To Establish Adjuvant Hub

The international outbreak of Ebola in 2014 serves as a reminder for the need to be proactive in preparing for the rapid spread of any newly emerging or re-emerging infectious disease. IDRI today announces it has received $4 million in funding from the Biomedical Advanced Research and Development Authority, part of the U.S. Department of Health and Human Services, to develop an adjuvant manufacturing hub with both preclinical and clinical expertise to facilitate pandemic influenza preparedness in developing countries. [More]
Training modules for emergency department staff to treat infectious disease patients available on CDC's website

Training modules for emergency department staff to treat infectious disease patients available on CDC's website

Four Web-based training modules developed by Johns Hopkins Medicine for emergency department personnel who treat patients with infectious diseases are now available on the Centers for Disease Control and Prevention website. [More]
UT Southwestern researchers identify common signaling mechanism that controls immune system

UT Southwestern researchers identify common signaling mechanism that controls immune system

UT Southwestern Medical Center researchers have identified a common signaling mechanism to produce interferon - one of the main proteins used to signal the immune system when the body needs to defend itself against a virus, tumor, or other diseases. [More]
New antibody shows promise in increasing survival for patients suffering from influenza, pneumonia

New antibody shows promise in increasing survival for patients suffering from influenza, pneumonia

Scientists from NTU Singapore, the world's No. 1 young university, have developed an antibody which boosts the survival chances for patients suffering from influenza and pneumonia. [More]
Immune system exploits flu virus' dependence on host's machinery

Immune system exploits flu virus' dependence on host's machinery

Viruses are masters of outsourcing, entrusting their fundamental function - reproduction - to the host cells they infect. But it turns out this highly economical approach also creates vulnerability. [More]
SIB Swiss Institute of Bioinformatics designated as FAO Reference Centre for bioinformatics

SIB Swiss Institute of Bioinformatics designated as FAO Reference Centre for bioinformatics

The Food and Agriculture Organization of the United Nations (FAO) has appointed SIB Swiss Institute of Bioinformatics as the FAO Reference Centre for bioinformatics. [More]
SRI Biosciences awarded contract to develop novel polymers to neutralize chemical, biological threats

SRI Biosciences awarded contract to develop novel polymers to neutralize chemical, biological threats

SRI Biosciences, a division of SRI International, has been awarded a $10 million contract under a DARPA program to reimagine how proteins are constructed and to develop novel medicines and diagnostics as countermeasures to chemical and biological threats. [More]

Alere reports net revenue of $666.9 million for fourth quarter 2014

Alere Inc., a global leader in rapid diagnostics, announced its financial results for the quarter ended December 31, 2014. [More]
Researchers assess causes of febrile illnesses in Tanzanian children

Researchers assess causes of febrile illnesses in Tanzanian children

Valérie D'Acremont led the research team from the Swiss Tropical and Public Health Institute in Basel and the Policlinique Médicale Universitaire in Lausanne, who systematically assessed the causes of febrile illnesses in Tanzanian children. According to the published paper, in most cases a treatment with antimalarials or antibiotics is not required. [More]
UM SOM launches ‘Program in Lung Healing’ to develop treatments for acute respiratory failure

UM SOM launches ‘Program in Lung Healing’ to develop treatments for acute respiratory failure

University of Maryland School of Medicine (UM SOM) Dean E. Albert Reece, MD, PhD, MBA, and Jeffrey A. Rivest, MS, President and Chief Executive Officer of University of Maryland Medical Center (UMMC), today announced the official launch of a new "Program in Lung Healing," that will further the School's position as a national leader in research, education and clinical innovation for acute ailments of the lung and respiratory system. [More]
Davita Kidney Care exceeds its own previous immunization rates for dialysis patients, teammates

Davita Kidney Care exceeds its own previous immunization rates for dialysis patients, teammates

DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, today announced that the company is a leader in immunizations for kidney care providers and has exceeded its own previous immunization rates for both dialysis patients and teammates. [More]
Johns Hopkins researchers reveal that e-cigarettes weaken immune system

Johns Hopkins researchers reveal that e-cigarettes weaken immune system

In a study with mice, Johns Hopkins Bloomberg School of Public Health researchers have found that e-cigarettes compromise the immune system in the lungs and generate some of the same potentially dangerous chemicals found in traditional nicotine cigarettes. [More]
Researchers suggest novel concept for developing vaccines against HIV and cancer

Researchers suggest novel concept for developing vaccines against HIV and cancer

A experimental trial has shown successful by inducing serum in mice and has been highly neutralizing towards those ailments. [More]
Using NMR to study influenza and TB: an interview with Dr. Tim Cross

Using NMR to study influenza and TB: an interview with Dr. Tim Cross

In this interview, Tim Cross, Director of the NMR and MRI programs at the National High Magnetic Field Lab (NHMFL) in Tallahassee, Florida, talks about his research into protein structures in viruses and bacteria, and how the findings will affect medical research into disease prevention. [More]
Cities with Super Bowl teams see big spike in flu illness, deaths

Cities with Super Bowl teams see big spike in flu illness, deaths

Boston and Seattle football fans beware! Cities with teams in the Super Bowl see a big spike in flu deaths, according to a new Tulane University study. [More]